Stocks · Health care · Services-Medical Laboratories

SERA PROGNOSTICS, INC.

SERA Clue Score24
United States Fiscal year ends December CIK 0001534969 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Paul Kearney
2 Dec 2025
Chief Data Officer
Sold after exercise
32,203
$2.94
$94.68K
Paul Kearney
26 Nov 2025
Chief Data Officer
Sold after exercise
1,986
$3.51
$6.97K
John J. Boniface
28 Mar 2024
Chief Scientific Officer
Sold after exercise
24,474
$9.04
$221.24K
John J. Boniface
27 Mar 2024
Chief Scientific Officer
Sold after exercise
48,909
$9.62
$470.50K
John J. Boniface
27 Mar 2024
Chief Scientific Officer
Sold after exercise
3,753
$9.62
$36.10K
John J. Boniface
27 Jul 2022
Chief Scientific Officer
Sold after exercise
1,000
$2.22
$2.22K
John J. Boniface
29 Jun 2022
Chief Scientific Officer
Sold after exercise
1,000
$1.72
$1.72K
John J. Boniface
1 Jun 2022
Chief Scientific Officer
Sold after exercise
1,000
$1.36
$1.36K
John J. Boniface
4 May 2022
Chief Scientific Officer
Sold after exercise
1,000
$2.17
$2.17K
John J. Boniface
6 Apr 2022
Chief Scientific Officer
Sold after exercise
1,000
$3.02
$3.02K

What was left out

Form 4 filings counted 283
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 43
Sales straight out of an exercise 10
Sales at will 161
Transactions with no price 0
Shares from compensation/vesting 13,000,720
Sales filed before the plan box existed 20
History held since 21 Jul 2021